New paper in Immunity shows microplastics are disrupting efferocytosis.
We're changing our environment faster than our biology can adapt. Understanding the immunological consequences of pollution is central to human health.
New paper in Immunity shows microplastics are disrupting efferocytosis.
We're changing our environment faster than our biology can adapt. Understanding the immunological consequences of pollution is central to human health.
Of Barriers and Loops—How Evolution Limits Most Cancer Risks to Older Ages url: aacrjournals.org/cancerdiscov...
Incredible work demonstrating a functional role for malignant cell states in preclinical lung cancer models
www.nature.com/articles/s41...
Cytokines are tricky to study, let alone in vivo. New tool to study cells that respond to cytokine receptor activation
It’s time to talk about epithelial geometry and cancer. How can the architecture of an epithelium affect how tumors will grow and spread? In this thread, @jorgealmagro.bsky.social
Paul Nurse describing the main job of a PI
(From ‘The Thinking Game’, 2024)
6 incredible years. So grateful for the opportunity to work with such brilliant people. What an adventure. Goodbye @crick.ac.uk
Diagram illustrating the two-hit model of retinoblastoma
To better treat cancer, we need to understand its underlying biology. Despite decades of research, some fundamental questions remain unanswered. One is why certain key tumor suppressor or oncogenes lead to cancer predominantly in single tissue: e.g. Rb in the retina, or APC in the colon 1/n 🧪
Thank you!!
Thanks Helen! Definitely!
Thank you! Hopefully cross paths soon!
Thrilled to announce I'm moving to Manchester to lead the Cancer Origins group! If you're interested in how mutations and exposures drive tumourigenesis — come join the adventure
William Hill is presenting his work on air pollutants in lung adenocarcinoma in a fascinating session exploring ageing and environmental factors in the development and spread of lung cancer.
#AACR25 | @drwilliamhill.bsky.social | @crick.ac.uk
Very interesting, I hadn't seen this. I know p53 mutations occur in normal lung tissue. Will be interesting to test the association of presence/absence of p53 mutations and expansion/selection of those mutations in people who smoke and those who don't.
Imaging mass cytometry of 122 early stage lung adeno patients explores the balance of of the tumour microenvironment and changes in malignant cell fate.
New to bluesky, but I’m excited to share my work over the last few years with @jbuenrostro.bsky.social! Chronic inflammation creates an epigenetic memory in colonic stem cells, priming them for tumor growth: tinyurl.com/ColitisNagar.... Here’s a walkthrough of what we found (🧵)
It is with great sadness to hear that the great Tim Radford has died. He was, unequivocally, the best science journalist, and a kind and generous man. I used his Manifesto for the Simple Scribe in lectures for student this very week. It’s faultless.
www.theguardian.com/science/blog...
I had a fantastic day at the CRUK workshop last week at the intersection between aging and cancer.
That's cool
At individual level those who vape more likely to go on to smoke (but causality not proven) but at population level higher levels of youth vaping could mean lower levels of youth smoking - really important work from @jhb19.bsky.social showing how carefully we need to keep the evidence under review
Today our study using copy number alterations (CNAs) from low-coverage WGS to predict FUTURE colorectal cancer in patients with IBD is published, details in thread! 1/5
gut.bmj.com/content/earl...
One of my frustrations with our work to understand the causes of #cancer #cachexia as part of Cancer Grand Challenges Team #CANCAN is the limitation of animal models that don't reflect the realities of the patient population. This development helps. #LCSM #lungcancer
www.biorxiv.org/content/10.1...
Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
https://buff.ly/4akMe3C
While further prospective validation is required, this approach could significantly enhance risk stratification and treatment planning in early-stage LUAD.
Ever wonder if the innate immune system protects against cancer in premalignancy? My lab reports that the inflammasome in bone marrow stroma suppresses Ras in preleukemic stem cells restraining lymphomagenesis.
Happy to share here: www.nature.com/articles/s41...
I'm delighted to announce that the Pharma Proteomics Project will commence full-scale proteomic profiling of the UK Biobank in 2025. We have selected the Olink Proteomics Explore HT platform and Ultima Genomics UG 100 sequencers for this unprecedented study.
www.ukbiobank.ac.uk/learn-more-a...
"unlike type 1 immune responses, type 2 immunity is perceived as a potential promoter of tumorigenesis. Emerging evidence challenges this perspective, painting a more nuanced picture in which type 2 immunity might protect against or even actively suppress tumour growth and progression." #ImmunoSky
Metabolic changes at the interface between mutant and normal skin epidermis www.nature.com/articles/s41...
But also who will I listen to the Rest is politics with in ex3?!
Congratulations!